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Improving Emergence and Awaken time in the Obese Population: Development of a Desflurane
Protocol in the Obese Population
Nikki Watson BSN, RN
Summary
Introduction to the Problem
The prevalence of obesity has continued to grow. As of 2014, 36.5% of the United States
population is obese (Center for Disease Control and Prevention, 2014). Illinois is one of 20 states
in which 30-35% of the population is obese (Center for Disease Control and Prevention, 2016).
Obesity increases the risk of several comorbidities. These comorbidities can result in
complications during the perioperative period. Obstructive sleep apnea (OSA) and delayed
gastric emptying are common risk factors associated with obesity (Kaw, Gali, & Collop, 2011).
Both OSA and delayed gastric emptying can complicate the perioperative course. Patients with
OSA also had a significantly longer post-anesthesia care unit (PACU) length of stay (Brousseau,
Dobson, & Milne, 2014). Sakai et al. (2006) conducted a retrospective study which showed lack
of protective reflexes (coordination of swallowing and respiration). Moreover, obesity has been
associated with increased risk of perioperative pulmonary aspiration (PPA) (Sakai et al., 2006).
Shorter-acting anesthetics, such as Desflurane may decrease the incidence of apnea or
desaturation in the PACU, thereby, decreasing the length of stay in the post-operative unit. Slow
emergence can delay the time until protective reflexes return, increasing the risk for aspiration of
stomach contents. Faster emergence has the potential to decrease the risk of aspiration.
Literature Review
Inhalation agents with a higher blood gas partition coefficient (higher solubility) have a
slower onset and recovery (Khan, Hayes, & Buggy, 2014). When comparing inhalation agents,

Desflurane has the lowest blood-gas and oil-gas coefficient (Khan, Hayes, & Buggy, 2014).
Multiple studies showed patients both obese and those with a normal body mass index (BMI) to
have a faster wake-up time when Desflurane was used over Sevoflurane, Isoflurane, and
Propofol (Clla, Albertin, Colla, & Mangano, 2007; De Baerdemaeker et al., 2003; Ergonenc,
Ergonenc, & Bican, 2014; Kaur, Jain, Sehgal, & Sood, 2013; Juvin, Vadam, Malek, Dupont,
Marmuse, & Desmonts, 2000; Liu et al., 2014; Strum et al., 2004; Wachtel, Dexter, Epstein, &
Ledolter, 2011; Werner et al., 2015). The definition of “awake” varied with each study. Several
of the studies measured the time from when Desflurane was discontinued to the time when a
patient could open their eyes and met extubation criteria. Some studies used scales such as the
Modified Aldrete Score (MAS) system and Short Orientation-Memory-Concentration test
(SOMCT) to assess a patient’s cognitive function. While the methods of assessing a patient’s
cognitive function varied, all the studies had similar results. Although a faster wake-up time is
ideal for all patients, some patients such as those with obesity are at higher risk for complications
that are associated with slower wake-up times.
Methodology
This project was a non-experimental quality improvement protocol and did not require
data collection from patients. A protocol was developed using evidence-based research from the
articles presented in the literature review. The Desflurane protocol served as a template for the
anesthesia staff at a Central Illinois community hospital to use as an anesthetic guide for the care
of the obese population. The protocol consisted of pre-operative assessment tools and a
questionnaire to assess the risk of aspiration and obstructive sleep apnea, as well as, the
definition used to define obesity. The protocol included; indications, contraindications, and how
to administer Desflurane for induction and maintenance. The protocol was implemented utilizing

an educational PowerPoint presented to the anesthesia and the pharmacy staff. A total of five
staff members were present for the presentation. A voluntary survey using true/false questions
(appendix b) assessed the effectiveness of the presentation and protocol. The final question used
a Likert scale from 1 to 5 was used to assess the likelihood of using Desflurane in the obese
population.
No patient information or data was collected for this project. Therefore, this project
received an exempt IRB from Southern Illinois University Edwardsville. The risks were minimal
for the participants who attended the presentation and completed the survey.
Evaluation
Results from the current study showed an increase in knowledge following the
presentation of Desflurane in the obese population. Five individuals attended the presentation for
the Desflurane protocol. Of the five, four were anesthesia providers (three registered nurse
anesthetists and one anesthesiologist). The fifth individual was a member of the pharmacy staff.
Four of the providers were male. The age of the individuals ranged from 30-64, and the majority
(four out of five) had eleven to twenty-four years of experience in their field of expertise.
Following the demographic questions, five questions were used to assess the understanding of
the presentation’s information. All staff members (100%) identified inhalation agents with higher
blood-gas and oil-gas coefficient has a slower onset and recovery. Every staff member (100%)
recognized Desflurane as having the lowest blood-gas and oil-gas coefficient. All participants
(100%) identified 30-35% of Illinois’ population as being obese. Every staff member (100%)
correctly answered the true or false question that stated, “obesity decreases the risk for apnea and
aspiration during the postoperative period.” All staff members (100%) recognized Desflurane as
having the fastest wake-up time in the obese population. The staff members (100%) agreed that

they do not routinely use Desflurane in the obese population due to lack of access and cost. At
the end of the survey, a Likert scale from 1 to 5 was used to assess the likelihood of using
Desflurane in the obese population. The majority of participants (80%) strongly agreed to use
Desflurane as their primary agent in the obese population as a result of the presentation. There
were no barriers to presenting the project. However, there were limitations to this project. For
example, the sample size was small with only five participants. Therefore, the results cannot be
generalized to a larger population.
Impact on Practice
The goal of this project was to develop a Desflurane protocol for the obese population
founded in evidence-based research and present the protocol to the anesthesia and pharmacy staff
at a Central Illinois community hospital. The objectives consist of the staff members being able
to verbalize the anesthesia risk associated with slow wake-ups in the obese population and list
the benefits of using Desflurane over other general anesthetic agents. Before this project,
Desflurane was not routinely used as the primary anesthetic in the obese population among the
anesthetic providers at a Central Illinois community hospital. The results showed that the
anesthesia staff supports the implementation of this protocol. Currently, the anesthesia staff and
pharmacy staff are working to estimate the cost of Desflurane and signing a contract with Baxter.
An improvement to the project in the future would be to implement during an anesthesia meeting
or to implement the project at more than one facility in order to increase the sample size
population. With an increase in sample size, the results could be generalized to a larger
population. Implementation of this protocol will benefit obese patients by reducing the risk for
apnea and aspiration during recovery. Shorter wake-up times will decrease the length of stay in
the PACU making the Desflurane protocol more cost effective for the hospital. A decrease in

PACU length of stay will allow for faster turnover, therefore, more surgeries can be performed
allowing a larger portion of the community to be served.
Conclusion
Recovery time from anesthesia can improve patient outcomes and decrease PACU stay
by using the Desflurane protocol in the obese population. The evidence-based research has been
reviewed and demonstrates Desflurane having the fastest wake-up time compared to any other
general anesthetic agent (Clla, Albertin, Colla, & Mangano, 2007; De Baerdemaeker et al., 2003;
Ergonenc, Ergonenc, & Bican, 2014; Kaur, Jain, Sehgal, & Sood, 2013; Juvin, Vadam, Malek,
Dupont, Marmuse, & Desmonts, 2000; Liu et al., 2014; Strum et al., 2004; Wachtel, Dexter,
Epstein, & Ledolter, 2011; Werner et al., 2015). Results from the survey showed that the
anesthesia staff support the use of Desflurane and strongly agree to use Desflurane in the future
as their primary anesthetic in the obese population. Presenting and providing St. Francis Hospital
with this protocol has the potential to improved wake-up times and decreased the risk for
complications found in the obese population due to slower wake-up times. Decreasing wake-up
times in the obese population will reduce the risk of apneic periods and aspiration in the PACU
leading to shorter PACU stays and improving patient satisfaction. Shorter PACU stays will
benefit the hospital by increasing patient turnover rates and decreasing cost associated with postoperative complications.
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